Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials
Brunilda Alushi(Deutsches Herzzentrum der Charité), Adnan Kastrati(Deutsches Herzzentrum München), Stefanie Schüpke, Himanshu Rai(Deutsches Herzzentrum München), Róisín Colleran(Deutsches Herzzentrum München), Salvatore Cassese, Ulf Landmesser(Deutsches Herzzentrum der Charité), Heribert Schunkert(German Centre for Cardiovascular Research), Bernhard Meier(University of Bern), Alexander Lauten(German Centre for Cardiovascular Research)
Cited by 15
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k